These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 660339

  • 1. 1-deamino-8-D-arginine vasopressin in the treatment of central diabetes insipidus in childhood.
    Becker DJ, Foley TP.
    J Pediatr; 1978 Jun; 92(6):1011-5. PubMed ID: 660339
    [Abstract] [Full Text] [Related]

  • 2. Vasopressin analog DDAVP in the treatment of diabetes insipidus.
    Lee WP, Lippe BM, La Franchi SH, Kaplan SA.
    Am J Dis Child; 1976 Feb; 130(2):166-9. PubMed ID: 766613
    [Abstract] [Full Text] [Related]

  • 3. Treatment of diabetes insipidus with DDAVP.
    Kikugawa CA, Cortopassi RF, Ditmer DG, Okamoto WS.
    Am J Hosp Pharm; 1977 Sep; 34(9):1013-7. PubMed ID: 906988
    [Abstract] [Full Text] [Related]

  • 4. Diabetes insipidus treated by DDAVP.
    Short JR, Isles A.
    Med J Aust; 1976 May 15; 1(20):756-7. PubMed ID: 958068
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Urinary adenosine 3',5'-monophosphate (cAMP) response to antidiuretic hormone in diabetes insipidus (DI): comparison between congenital nephrogenic DI type 1 and 2, and vasopressin sensitive DI.
    Ohzeki T.
    Acta Endocrinol (Copenh); 1985 Apr 15; 108(4):485-90. PubMed ID: 2986401
    [Abstract] [Full Text] [Related]

  • 8. Neurogenic diabetes insipidus: management with dDAVP (1-desamino-8-D arginine vasopressin).
    Cobb WE, Spare S, Reichlin S.
    Ann Intern Med; 1978 Feb 15; 88(2):183-8. PubMed ID: 626447
    [Abstract] [Full Text] [Related]

  • 9. Effects of DDAVP in cranial diabetes insipidus as compared to other antidiuretic drugs.
    Coculescu M, Antipa C, Cucu C.
    Endocrinologie; 1977 Feb 15; 15(4):275-81. PubMed ID: 563614
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The treatment of patients with diabetes insipidus by a synthetic analogue of vasopressin, DDAVP (author's transl)].
    Tanae A, Shimizu K, Yoshida S.
    Nihon Naibunpi Gakkai Zasshi; 1978 May 20; 54(5):676-91. PubMed ID: 689212
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Long-term treatment of central diabetes insipidus with oral DDAVP].
    Carraro A, Fano M, Cuttica M, Bernareggi V, Giusti M, Giordano G.
    Minerva Endocrinol; 1992 May 20; 17(4):189-93. PubMed ID: 1308923
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Central diabetes insipidus in children. V. Oral treatment with a vasopressin hormone analogue (DDAVP).
    Fjellestad A, Czernichow P.
    Acta Paediatr Scand; 1986 Jul 20; 75(4):605-10. PubMed ID: 3529809
    [Abstract] [Full Text] [Related]

  • 19. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
    Lebacq E, David L.
    Pediatrie; 1975 Jul 20; 30(3):265-270. PubMed ID: 1178251
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.